Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(5 sites)
United States
University of Southern California, Los Angeles, California University of Illinois Chicago, Chicago, Illinois New York University Langone Medical Center, New York, New York The Ohio State University, Columbus, Ohio University of Pittsburgh, Pittsburgh, Pennsylvania Age range
18 Years and older
Last updated October 2025